Blackham A and Griffiths RJ |
The effect of FK506 and cyclosporin A on antigen-induced arthritis. |
1991 |
Clin. Exp. Immunol. |
pmid:1718639
|
Carobbi A et al. |
Effect of splenectomy in combination with FK 506 and 15-deoxyspergualin on cardiac xenograft survival. |
1991 |
Transplant. Proc. |
pmid:1703704
|
Ericzon BG et al. |
Pharmacokinetics of FK 506 during maintenance therapy in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721273
|
Jain AB et al. |
Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721274
|
McMichael J et al. |
Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1721275
|
Rosborough SL et al. |
Identification of FKBP-related proteins with antibodies of predetermined specificity and isolation by FK 506 affinity chromatography. |
1991 |
Transplant. Proc. |
pmid:1721306
|
Zeevi A et al. |
In vitro assessment of FK 506 immunosuppressive activity in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721307
|
Shaw BW et al. |
FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients. |
1991 |
Transplant. Proc. |
pmid:1721338
|
McDiarmid SV et al. |
FK 506 rescue therapy in liver transplantation: outcome and complications. |
1991 |
Transplant. Proc. |
pmid:1721339
|
Tzakis AG et al. |
Use of FK 506 in pediatric patients. |
1991 |
Transplant. Proc. |
pmid:1703353
|
Fries D et al. |
Development of renal dysfunction and renal histological lesions in two patients treated with FK 506 for acute rejection following liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721370
|
Jain AB et al. |
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1703354
|
Wijnen RM et al. |
Toxicity of FK 506 in the cynomolgus monkey: noncorrelation with FK 506 serum levels. |
1991 |
Transplant. Proc. |
pmid:1721371
|
Venkataramanan R et al. |
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703355
|
Viebahn R et al. |
Hypoxic and reoxygenation injury in human and rat hepatocytes--influence of FK 506 and cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721401
|
Morrisett JD et al. |
Effect of FK 506 and cyclosporine on plasma cholesterol levels in rabbits. |
1991 |
Transplant. Proc. |
pmid:1721402
|
Valdivia LA et al. |
Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721432
|
Wu GD et al. |
FK 506 inhibits the development of transplant arteriosclerosis. |
1991 |
Transplant. Proc. |
pmid:1721433
|
Kobayashi N et al. |
Effect of FK 506 on abdominal organ cluster transplantation in pigs. |
1991 |
Transplant. Proc. |
pmid:1721434
|
Michnick SW et al. |
Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin. |
1991 |
Science |
pmid:1709301
|
Van Duyne GD et al. |
Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. |
1991 |
Science |
pmid:1709302
|
Lim SM and White DJ |
The pharmacology of immunosuppression. |
1991 |
Ann. Acad. Med. Singap. |
pmid:1709344
|
Staruch MJ et al. |
Differential effects of the immunosuppressive macrolides FK-506 and rapamycin on activation-induced T-cell apoptosis. |
1991 |
Int. J. Immunopharmacol. |
pmid:1721613
|
Matsuura T et al. |
[Experimental studies on the mode of action of cyclosporine and FK506 assessed by proliferation response of human cloned T lymphocytes]. |
1991 |
Hinyokika Kiyo |
pmid:1721767
|
Jin YJ et al. |
Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13. |
1991 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1713687
|
Murase N et al. |
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. |
1991 |
Surgery |
pmid:1714104
|
Jiang H et al. |
Effect of FK 506 on heart allograft survival in highly sensitized recipient rats in comparison with cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703702
|
Jordan ML et al. |
Initial studies with FK506 in renal transplantation. |
1991 Sep-Oct |
Cleve Clin J Med |
pmid:1718631
|
Stangl MJ et al. |
The use of FK506 and RS61443 for reversal of small-bowel rejection. |
1992 |
Transpl. Int. |
pmid:14621800
|
Wijnen RM et al. |
Toxicology of FK506 in the cynomolgus monkey: a clinical, biochemical, and histopathological study. |
1992 |
Transpl. Int. |
pmid:14621844
|
Jiang H et al. |
Control of humoral and cellular immunity-mediated accelerated heart allograft rejection in sensitized rats by low dose FK 506 and splenectomy. |
1992 |
Transpl. Int. |
pmid:14621859
|
Hanawa H et al. |
An immunosuppressant compound, FK-506, prevents the progression of autoimmune myocarditis in rats. |
1992 |
Clin. Immunol. Immunopathol. |
pmid:1371730
|
Hiraoka Y et al. |
The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis. |
1992 |
J. Pharmacol. Exp. Ther. |
pmid:1372051
|
Chen TS et al. |
Microbial transformation of immunosuppressive compounds. I. Desmethylation of FK506 and immunomycin (FR 900520) by Actinoplanes sp. ATCC 53771. |
1992 |
J. Antibiot. |
pmid:1372307
|
Sigal NH and Dumont FJ |
Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. |
1992 |
Annu. Rev. Immunol. |
pmid:1375473
|
Chen TS et al. |
Microbial transformation of immunosuppressive compounds. II. Specific desmethylation of 13-methoxy group of FK 506 and FR 900520 by an unidentified Actinomycete ATCC 53828 [corrected]. |
1992 |
J. Antibiot. |
pmid:1375593
|
Demetris AJ et al. |
Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression. |
1992 |
Lancet |
pmid:1376851
|
Ichihashi T et al. |
Haemolytic uraemic syndrome during FK506 therapy. |
1992 |
Lancet |
pmid:1376852
|
DiLella AG et al. |
Chromosomal band assignments of the genes encoding human FKBP12 and FKBP13. |
1992 |
Biochem. Biophys. Res. Commun. |
pmid:1281998
|
Sawada M et al. |
Down regulation of CD4 expression in cultured microglia by immunosuppressants and lipopolysaccharide. |
1992 |
Biochem. Biophys. Res. Commun. |
pmid:1282000
|
Minoda M et al. |
Effects of gamma-interferon and FK506 on resting B cell proliferation of New Zealand black/white F1 mice. |
1992 |
Microbiol. Immunol. |
pmid:1282197
|
Yoshimura R et al. |
A comparative study of cyclosporine vs FK 506: role of kidney microsomal cytochrome P-450. |
1992 |
Transplant. Proc. |
pmid:1379755
|
Yamada K et al. |
FK 506-induced juxtaglomerular apparatus hyperplasia and tubular damage in rat kidney--morphologic and biologic analysis. |
1992 |
Transplant. Proc. |
pmid:1379756
|
Fukuse T et al. |
Optimal dose of FK 506 in canine lung allotransplantation. |
1992 |
Transplant. Proc. |
pmid:1379757
|
Wada H et al. |
Combination use of suboptimal doses of FK 506 and cyclosporine in canine lung transplantation. |
1992 |
Transplant. Proc. |
pmid:1379758
|
Karpas A et al. |
Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. |
1992 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1381509
|
Yatscoff RW and Shaw LM |
Therapeutic monitoring of cyclosporine, FK-506, and rapamycin. |
1992 |
Ther Drug Monit |
pmid:1381530
|
Arceci RJ et al. |
Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. |
1992 |
Blood |
pmid:1381629
|
Mochizuki M et al. |
Preclinical and clinical study of FK506 in uveitis. |
1992 |
Curr. Eye Res. |
pmid:1385045
|
Chung J et al. |
Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. |
1992 |
Cell |
pmid:1377606
|